Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit

Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in NICU

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07150494

Enrollment

Registered

2025-09-02

Start date

2025-10-01

Completion date

2026-10-01

Last updated

2025-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Hyperbilirubinemia

Brief summary

Early detection and prevention of neonatal encephalopathy using BIND score.

Interventions

DEVICEPhototherapy

Phototherapy used to decrease high billirubin level in neonatal jaundice

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to 28 Days

Inclusion criteria

Newborn \< 28 days old Neonates with severe hyperbilirubinemia need extensive phototherapy impending exchange transfusion

Exclusion criteria

Age \> 28 days old Neonates with any abnormal neurological signs suggesting neurological disease (hypoxic ischemic encephalopathy, muscle disease, …etc.).

Design outcomes

Primary

Measure	Time frame	Description
Decrease high billirubin level	One year duration	We use bind score to evaluate neurological condition of neoborns then use photo therapy to decrease
Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU	Baseline	Early detection and prevention of neonatal encephalopathy using BIND score.

Contacts

Primary ContactNouralhoda Ahmed Metwally

nouralhoda2712@gmail.com+201012527376

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026